相关实验视频

Updated: Sep 13, 2025

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

RAAS抑制剂的免疫调节作用:超越高血压和心力衰竭

Raluca Ecaterina Haliga^1,2, Elena Cojocaru³, Oana Sîrbu^1,2

¹Internal Medicine and Toxicology Department, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.

|July 29, 2025

概括

氨酸- ангиотензин- алдостерон系统 (RAAS) 抑制剂,包括ACE抑制剂和ARBs,表现出广泛的免疫调节作用. 这些药物提供了超越心血管疾病的治疗潜力,影响自身免疫,瘤和神经退行性疾病.

科学领域:

心血管和脏生理学
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

氨酸- ангиотензин- алдостерон系统 (RAAS) 对于心血管和脏平衡至关重要.
RAAS在调节免疫反应方面发挥着重要作用.
药理上RAAS抑制主要通过ACE抑制剂 (ACEI) 和ARBs实现.

研究的目的:

探索RAAS抑制剂超出其已确定的心血管应用的免疫调节作用.
研究ACEI和ARB在各种系统性病理中的治疗潜力.
阐明RAAS抑制的免疫效应背后的Ang II依赖和独立的机制.

主要方法:

审查关于RAAS抑制剂及其免疫调节作用的现有文献.
对免疫细胞上ACEI和ARB的Ang II依赖和独立机制的分析.
对自身免疫性,传染性,瘤性和神经退行性疾病中RAAS抑制的临床和临床前数据的检查.

主要成果:

ACEI和ARBs调节先天性和适应性免疫,影响巨细胞分化,T细胞分化和细胞因子产生.
通过调节粉样β代谢,ACEI表现出Ang II独立的神经保护作用.
ARBs (特尔米沙坦,坎德沙坦) 通过PPARγ激活提供抗炎功效.
抑制RAAS会影响瘤生长,血管生成和癌症中的免疫监测.
在自身免疫性心肌炎,大肠炎和糖尿病病的临床前模型中,ACEI显示出有效性.

结论:

RAAS 抑制剂具有显著的免疫调节特性,在各种疾病中具有治疗意义.
ACEI和ARB在神经退行性疾病,癌症和自身免疫性疾病中具有潜在的益处.
需要进一步的临床研究来证实RAAS抑制剂在各种病理环境中的长期疗效和结果.

关键词:

ACE 抑制剂是一种 ACE 抑制剂.阻碍RAAS的抑制作用免疫调节免疫调节免疫调节神经保护神经保护瘤微环境是一个微环境.

更多相关视频

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells

Published on: March 5, 2019

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Antihypertensive Drugs: Direct Renin Inhibitors

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...

Antihypertensive Drugs: Angiotensin II Receptor Blockers

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...

Heart Failure Drugs: Diuretics

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...

Hypertension II: Pathophysiology

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...